Cooled thermotherapy for the treatment of benign prostatic hyperplasia: Durability of results obtained with the Targis System

Urology

Volumn 61, Issue 6, 2003, Pages 1160-1164

  Miller, Paul D ^a   Kastner, Christof ^b   Ramsey, Ernest W ^b   Parsons, Keith ^b  

^a EAST SURREY HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIANDROGEN;

ADULT; AGED; ARTICLE; BLADDER CATHETERIZATION; CANADA; COMPUTER PROGRAM; DEVICE; FOLLOW UP; GENERAL ANESTHESIA; GENERAL CONDITION IMPROVEMENT; GENERATOR; HEALTH CENTER; HUMAN; HYPERTHERMIC THERAPY; MAJOR CLINICAL STUDY; MALE; MICROWAVE IRRADIATION; OUTPATIENT; PATIENT MONITORING; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUALITY OF LIFE; REGIONAL ANESTHESIA; SCORING SYSTEM; SURGICAL TECHNIQUE; SYMPTOM; TIME; TREATMENT OUTCOME; UNITED KINGDOM; URINE FLOW RATE;

EID: 0038616371     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(03)00337-6     Document Type: Article

References (12)

1. Ramsey E.W., Miller P.D., Parsons K. A novel transurethral microwave thermoablation system to treat benign prostatic hyperplasia results of a prospective multicenter clinical trial . J Urol. 158:1997;112-119.
2. Ramsey E.W., Miller P.D., Parsons K. Transurethral microwave thermotherapy in the treatment of benign prostatic hyperplasia results obtained with the Urologix T3 device . World J Urol. 16:1998;96-101.
3. Barry M., Williford W., Chang Y., et al. Benign prostatic hyperplasia specific health status measures in clinical research how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients? J Urol. 154:1995;1770-1774.
4. Djavan B., Shariat S., Fakhari M., et al. Neoadjuvant and adjuvant alpha-blockade improves early results of high energy transurethral microwave thermotherapy for lower urinary tract symptoms of benign prostatic hyperplasia a randomized, prospective clinical trial . Urology. 53:1999;252-259.
5. Dahlstrand C., Walden M., Patterson S. A cost-effectiveness analysis of TURP and TUMT for treatment of BPH seven-year follow-up . (abstract) J Endourol. 13:(suppl 1):1999;A111.
6. Larson T.R., Bostwick D.G., Corica A. Temperature correlated histopathologic changes following microwave thermoablation of obstructive tissue in patients with benign prostatic hyperplasia. Urology. 47:1996;463-469.
7. Carter S., Ogden C. Intraprostatic temperature versus clinical outcome in TUMT is the response heat-dose dependent? J Urol. 151:1994;416A.
8. Larson T.R., Blute M.L., Bruskewitz R.C., et al. A high efficiency microwave thermoablation system for the treatment of benign prostatic hyperplasia results of a randomized, sham-controlled, prospective, double-blind, multicenter clinical trial . Urology. 51:1998;731-742.
9. Thalmann G.N., Graber S.F., Bitton A., et al. Transurethral thermotherapy for benign prostatic hyperplasia significantly decreases infravesical obstruction results in 134 patients after 1 year . J Urol. 162:1999;387-393.
10. Djavan B., Roehrborn C.G., Shariat S., et al. Prospective randomized comparison of high energy transurethral microwave thermotherapy versus α-blocker treatment of patients with benign prostatic hyperplasia. J Urol. 161:1999;139-143.
11. Francisca E, Kortmann B, Debruyne F, et al: High energy transurethral microwave thermotherapy (TUMT 2.5): results 4-years following treatment. J Endourol 13(suppl 1): A118, 1999.
12. Djavan B., Seitz C., Roehrborn C.G., et al. Targeted transurethral microwave thermotherapy verse alpha-blockade in benign prostatic hyperplasia outcomes at 18 months . Urology. 57:2001;66-70.